GE HealthCare Technologies Inc. (GEHC) - Net Assets
Based on the latest financial reports, GE HealthCare Technologies Inc. (GEHC) has net assets worth $10.60 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($36.91 Billion) and total liabilities ($26.31 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check GEHC financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $10.60 Billion |
| % of Total Assets | 28.72% |
| Annual Growth Rate | -6.68% |
| 5-Year Change | -37.27% |
| 10-Year Change | N/A |
| Growth Volatility | 26.1 |
GE HealthCare Technologies Inc. - Net Assets Trend (2020–2025)
This chart illustrates how GE HealthCare Technologies Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore total assets of GE HealthCare Technologies Inc. for the complete picture of this company's asset base.
Annual Net Assets for GE HealthCare Technologies Inc. (2020–2025)
The table below shows the annual net assets of GE HealthCare Technologies Inc. from 2020 to 2025. For live valuation and market cap data, see GE HealthCare Technologies Inc. (GEHC) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $10.60 Billion | +22.49% |
| 2024-12-31 | $8.65 Billion | +18.37% |
| 2023-12-31 | $7.31 Billion | -23.79% |
| 2022-12-31 | $9.59 Billion | -43.23% |
| 2021-12-31 | $16.90 Billion | +12.84% |
| 2020-12-31 | $14.97 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to GE HealthCare Technologies Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 528100000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $5.28 Billion | 50.88% |
| Common Stock | $5.00 Million | 0.05% |
| Other Comprehensive Income | $-1.39 Billion | -13.37% |
| Other Components | $6.48 Billion | 62.44% |
| Total Equity | $10.38 Billion | 100.00% |
GE HealthCare Technologies Inc. Competitors by Market Cap
The table below lists competitors of GE HealthCare Technologies Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Wiwynn Corp
TW:6669
|
$27.84 Billion |
|
RYANAIR HLDGS ADR NEW/5
F:RY4D
|
$27.87 Billion |
|
Restaurant Brands International Inc
TO:QSR
|
$27.89 Billion |
|
Dover Corporation
NYSE:DOV
|
$27.95 Billion |
|
SHINHAN FINL ADR/1 SW5000
F:KSF1
|
$27.77 Billion |
|
CenterPoint Energy Inc
NYSE:CNP
|
$27.76 Billion |
|
Biogen Inc
NASDAQ:BIIB
|
$27.74 Billion |
|
DCI Indonesia Tbk PT
JK:DCII
|
$27.69 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GE HealthCare Technologies Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 8,447,000,000 to 10,379,000,000, a change of 1,932,000,000 (22.9%).
- Net income of 2,084,000,000 contributed positively to equity growth.
- Dividend payments of 64,000,000 reduced retained earnings.
- Share repurchases of 200,000,000 reduced equity.
- Other comprehensive income decreased equity by 9,000,000.
- Other factors increased equity by 121,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $2.08 Billion | +20.08% |
| Dividends Paid | $64.00 Million | -0.62% |
| Share Repurchases | $200.00 Million | -1.93% |
| Other Comprehensive Income | $-9.00 Million | -0.09% |
| Other Changes | $121.00 Million | +1.17% |
| Total Change | $- | 22.87% |
Book Value vs Market Value Analysis
This analysis compares GE HealthCare Technologies Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.71x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.88x to 2.71x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $32.39 | $61.04 | x |
| 2021-12-31 | $36.63 | $61.04 | x |
| 2022-12-31 | $20.61 | $61.04 | x |
| 2023-12-31 | $15.57 | $61.04 | x |
| 2024-12-31 | $18.40 | $61.04 | x |
| 2025-12-31 | $22.55 | $61.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GE HealthCare Technologies Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 20.08%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.10%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 3.56x
- Recent ROE (20.08%) is below the historical average (35.86%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 94.02% | 80.67% | 0.71x | 1.65x | $12.37 Billion |
| 2021 | 13.49% | 12.78% | 0.67x | 1.58x | $581.50 Million |
| 2022 | 20.48% | 10.45% | 0.67x | 2.94x | $980.30 Million |
| 2023 | 43.52% | 15.88% | 0.60x | 4.55x | $2.39 Billion |
| 2024 | 23.59% | 10.13% | 0.59x | 3.92x | $1.15 Billion |
| 2025 | 20.08% | 10.10% | 0.56x | 3.56x | $1.05 Billion |
Industry Comparison
This section compares GE HealthCare Technologies Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $385,987,292
- Average return on equity (ROE) among peers: -142.43%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GE HealthCare Technologies Inc. (GEHC) | $10.60 Billion | 94.02% | 2.48x | $27.82 Billion |
| Abbott Laboratories (ABT) | $3.35 Billion | 37.01% | 1.07x | $151.58 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $20.76 Million |
| Aethlon Medical Inc (AEMD) | $2.30 Million | -269.46% | 0.79x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $-11.59 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $280.85 Million | -57.55% | 5.46x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $4.29 Million | -149.07% | 0.49x | $15.42 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.44 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $1.96 Million | -680.21% | 0.05x | $4.32 Million |
| Artivion Inc (AORT) | $279.04 Million | 1.33% | 1.12x | $1.72 Billion |
| Apyx Medical Inc (APYX) | $6.01 Million | -36.31% | 0.22x | $114.47 Million |
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical… Read more